Cohance Lifesciences LtdNSE: COHANCE

Cohance Lifesciences Ltd Press Release Sep 03 2026

· Issued by Cohance Lifesciences Ltd via NSE India

Filed with NSE · · 4 pages · English

Summary by 6ix AI

The company plans to invest significantly in both entities to enhance their operational capabilities and market presence. This reorganization aims to strengthen NJ Bio's customer services and advance Aruka's drug development pipeline through strategic partnerships. The completion of these transactions is anticipated by the end of September, pending necessary approvals and agreements.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/cohance-lifesciences-ltd-press-release-sep-03-2026

Watch Cohance Lifesciences' latest callCohance Lifesciences (NSE:COHANCE) Q1 2027 Earnings Call · Replay · Aug 5Read the transcript of Cohance Lifesciences (NSE:COHANCE) Q1 2027 Earnings Call

Cohance Lifesciences Ltd on 6ix

Earlier from Cohance Lifesciences

All Cohance Lifesciences news releases